ENDRA Life Sciences Inc. SEC filings NDRA

ENDRA Life Sciences Inc. has 544 filings in SEC EDGAR's recent list, going back to Aug 9, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (material agreement). The company's fiscal year ends on December 31.

ENDRA Life Sciences Inc. SEC filings
Form Description Filed Period
425 Form 425 Oct 26, 2026 —
3 Initial insider ownership Oct 8, 2026 Oct 1, 2026
SCHEDULE 13D Ownership over 5% (active) Oct 8, 2026 —
S-4 Registration for a merger or exchange Oct 2, 2026 —
425 Current report Oct 1, 2026 —
8-K Current report
Material agreement
Oct 1, 2026 Oct 1, 2026
425 Form 425 Sep 25, 2026 —
425 Form 425 Sep 14, 2026 —
425 Filing Sep 9, 2026 —
425 Form 425 Sep 9, 2026 —
425 Form 425 Aug 21, 2026 —
425 Filing Aug 20, 2026 —
425 Current report Aug 17, 2026 —
8-K Current report
Results of operations
Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
425 Filing Aug 6, 2026 —
425 Filing Aug 5, 2026 —
425 Filing Aug 4, 2026 —
425 Filing Jul 22, 2026 —
425 Filing Jul 22, 2026 —
425 Form 425 Jul 17, 2026 —
425 Form 425 Jul 17, 2026 —
8-K Current report
Other events
Jul 9, 2026 Jul 8, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 29, 2026 —
425 Current report Jun 26, 2026 —
8-K Current report
Material agreement, Change in control, Regulation FD disclosure, Other events
Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 25, 2026 —
425 Filing Jun 25, 2026 —
425 Current report Jun 25, 2026 —
8-K Current report
Regulation FD disclosure
Jun 25, 2026 Jun 25, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
May 28, 2026 May 27, 2026
RW Withdrawal request May 26, 2026 —
S-8 Employee stock plan registration May 15, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Listing notice
Apr 21, 2026 Apr 20, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Mar 25, 2026 Mar 19, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Dec 15, 2025 Dec 9, 2025
8-K Current report
Officer or director change
Nov 28, 2025 Nov 28, 2025
SCHEDULE 13D Ownership over 5% (active) Nov 26, 2025 —
424B4 Prospectus Nov 26, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Other events
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3 Shelf registration Nov 6, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
8-K Current report
Material agreement
Oct 30, 2025 Oct 29, 2025
424B5 Prospectus supplement Oct 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 28, 2025 —
ARS Annual report to shareholders Oct 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Oct 28, 2025 —
DEF 14A Proxy statement Oct 28, 2025 Dec 31, 2024
D Filing Oct 24, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2025 Oct 23, 2025
PRE 14A Preliminary proxy statement Oct 17, 2025 Dec 31, 2024
4 Insider transaction Oct 15, 2025 Oct 10, 2025
8-K/A Amended current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
Oct 15, 2025 Oct 10, 2025
8-K Current report Oct 15, 2025 Oct 10, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
S-1/A Amended registration statement Jul 25, 2025 —
8-K Current report
Other events
Jul 23, 2025 Jul 23, 2025
S-1/A Amended registration statement Jul 16, 2025 —
8-K Current report
Results of operations
Jul 9, 2025 Jul 9, 2025
S-1 Registration statement Jul 9, 2025 —
4 Insider transaction Jul 1, 2025 Jun 11, 2025
4 Insider transaction Jul 1, 2025 Jun 11, 2025
4 Insider transaction Jul 1, 2025 Jun 11, 2025
8-K Current report
Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
8-K Current report
Listing notice
May 30, 2025 May 27, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
DRS Filing May 9, 2025 —
10-K/A Amended annual report Apr 7, 2025 Dec 31, 2024
S-8 Employee stock plan registration Apr 2, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 22, 2024 Nov 22, 2024
10-Q/A Amended quarterly report Nov 21, 2024 Sep 30, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 15, 2024 Nov 15, 2024
NT 10-Q Form nt 10-q Nov 15, 2024 Sep 30, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Nov 5, 2024 Nov 4, 2024
8-K Current report
Shareholder vote results, Other events
Oct 29, 2024 Oct 28, 2024
DEFA14A Additional proxy material Sep 17, 2024 —
DEF 14A Proxy statement Sep 16, 2024 Sep 6, 2024
PRE 14A Preliminary proxy statement Sep 6, 2024 Sep 6, 2024
4/A Primary document Sep 5, 2024 Aug 27, 2024
3/A Primary document Sep 5, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
3 Initial insider ownership Aug 29, 2024 Aug 27, 2024
8-K Current report
Regulation FD disclosure, Other events
Aug 28, 2024 Aug 28, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 23, 2024 Aug 22, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 16, 2024 Aug 16, 2024
3 Initial insider ownership Aug 15, 2024 Aug 8, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 13, 2024 Aug 12, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Aug 9, 2024 Aug 5, 2024
DEFA14A Additional proxy material Jul 17, 2024 —
8-K Current report
Listing notice
Jul 17, 2024 Jul 15, 2024
ARS Annual report to shareholders Jun 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Jun 25, 2024 —
DEF 14A Proxy statement Jun 25, 2024 Aug 6, 2024
SC 13G Ownership over 5% (passive) Jun 14, 2024 —
SC 13G Ownership over 5% (passive) Jun 14, 2024 —
PRE 14A Preliminary proxy statement Jun 12, 2024 Jun 11, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jun 6, 2024 Jun 4, 2024
424B3 Prospectus Jun 5, 2024 —
EFFECT Filing Jun 4, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
S-1/A Amended registration statement May 31, 2024 —
8-K Current report
Regulation FD disclosure, Other events
May 20, 2024 May 20, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2024 May 10, 2024
S-1/A Amended registration statement May 10, 2024 —
8-K Current report
Listing notice
May 3, 2024 May 3, 2024
UPLOAD Letter from the SEC Apr 29, 2024 —
S-1 Registration statement Apr 19, 2024 —
EFFECT Filing Apr 3, 2024 —
424B5 Prospectus supplement Apr 3, 2024 —
424B5 Prospectus supplement Apr 3, 2024 —
CORRESP Letter to the SEC Apr 1, 2024 —
S-8 Employee stock plan registration Mar 28, 2024 —
S-3/A Form s-3/a Mar 28, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
UPLOAD Letter from the SEC Feb 23, 2024 —
4 Insider transaction Feb 23, 2024 Jan 2, 2024
4 Insider transaction Feb 23, 2024 Jan 2, 2024
4 Insider transaction Feb 23, 2024 Jan 2, 2024
4 Insider transaction Feb 23, 2024 Jan 2, 2024
S-3 Shelf registration Feb 14, 2024 —
424B3 Prospectus Dec 29, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
424B5 Prospectus supplement Aug 14, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2023 Aug 14, 2023
8-K Current report
Shareholder vote results
Aug 10, 2023 Aug 9, 2023
DEFA14A Additional proxy material Jul 25, 2023 —
8-K Current report
Other events
Jul 25, 2023 Jul 25, 2023
8-K Current report
Other events
Jul 6, 2023 Jul 6, 2023
DEFA14A Additional proxy material Jul 6, 2023 —
ARS Annual report to shareholders May 24, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 24, 2023 —
DEF 14A Proxy statement May 24, 2023 Jul 6, 2023
4 Insider transaction May 22, 2023 May 18, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
4 Insider transaction May 3, 2023 May 2, 2023
8-K Current report
Material agreement, Regulation FD disclosure
May 2, 2023 Apr 27, 2023
424B5 Prospectus supplement Apr 28, 2023 —
S-1MEF Filing Apr 28, 2023 —
EFFECT Filing Apr 27, 2023 —
CORRESP Letter to the SEC Apr 24, 2023 —
CORRESP Letter to the SEC Apr 24, 2023 —
S-1/A Amended registration statement Apr 19, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure
Apr 18, 2023 Apr 18, 2023
S-1/A Amended registration statement Apr 18, 2023 —
UPLOAD Letter from the SEC Apr 7, 2023 —
S-1 Registration statement Mar 30, 2023 —
S-8 Employee stock plan registration Mar 16, 2023 —
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 14, 2023 Mar 14, 2023
SC 13G Ownership over 5% (passive) Mar 10, 2023 —
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
4 Insider transaction Feb 1, 2023 Jan 30, 2023
8-K Current report
Officer or director change
Dec 23, 2022 Dec 21, 2022
8-K Current report
Material agreement
Dec 19, 2022 Dec 16, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
8-K Current report
Bylaw or fiscal year change
Dec 8, 2022 Dec 8, 2022
8-K Current report
Shareholder vote results, Other events
Dec 2, 2022 Nov 29, 2022
4 Insider transaction Nov 28, 2022 Nov 23, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
DEFA14A Additional proxy material Oct 17, 2022 —
DEF 14A Proxy statement Oct 17, 2022 Nov 29, 2022
PRE 14A Preliminary proxy statement Sep 27, 2022 Nov 29, 2022
8-A12G Form 8-a12g Sep 27, 2022 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 27, 2022 Sep 27, 2022
4 Insider transaction Aug 24, 2022 Aug 22, 2022
4 Insider transaction Aug 24, 2022 Aug 22, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NDRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ann Arbor, MI
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1681682
Former names
Endra Inc. (until Sep 21, 2016)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.